Fore Pharmas latest report ‘Global Musculoskeletal Pain Drug Pipeline Capsule – 2011 is an outline of all the key research and development (R&D) activities of the global musculoskeletal pain drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the musculoskeletal pain drug market is thoroughly covered by company and licensee with the deal summary.

Key Features of the Report:
- Musculoskeletal Pain: Overview
- Musculoskeletal Pain Drug Pipeline Overview
- Musculoskeletal Pain Phase 3 Clinical Trial Drug Pipeline Insights
- Musculoskeletal Pain Phase 2 Clinical Trial Drug Pipeline Insights
- Musculoskeletal Pain Phase 1 Clinical Trial Drug Pipeline Insights
- Musculoskeletal Pain Preclinical Research Drug Pipeline Insights
- Musculoskeletal Pain Drug Discovery Pipeline Insights
- Geographic Landscape of Musculoskeletal Pain R&D Activities
- Musculoskeletal Pain R&D Activities in North America
- Musculoskeletal Pain R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Musculoskeletal Pain Drug Market

1. Musculoskeletal Pain: Disease Definition
2. Musculoskeletal Pain Drug Pipeline Overview
3. Musculoskeletal Pain Phase 3 Clinical Trial Drug Pipeline Insights
4. Musculoskeletal Pain Phase 2 Clinical Trial Drug Pipeline Insights
5. Musculoskeletal Pain Phase 1 Clinical Trial Drug Pipeline Insights
6. Musculoskeletal Pain Preclinical Research Drug Pipeline Insights
7. Musculoskeletal Pain Drug Discovery Pipeline Insights
8. Geographic Landscape of Musculoskeletal Pain R&D Activities
8.1 Musculoskeletal Pain R&D Activities in North America
8.2 Musculoskeletal Pain R&D Activities in Europe
9 Licensing Activities / Partnerships in the Global Musculoskeletal Pain Drug Market
10 Research Methodology Table 1: Musculoskeletal Pain Drug Pipeline: Phase 3 Clinical Trial

Table 2: Musculoskeletal Pain Drug Pipeline: Phase 2 Clinical Trial
Table 3: Musculoskeletal Pain Drug Pipeline: Phase 1 Molecules
Table 4: Musculoskeletal Pain Drug Pipeline: Preclinical Research
Table 5: Musculoskeletal Pain R&D Activities by Geography
Table 6: Musculoskeletal Pain Drug Pipeline: North America
Table 7: Musculoskeletal Pain Drug Pipeline: Europe
Table 8: Musculoskeletal Pain Drug Pipeline: Licensing Activities

Figure 1 : Musculoskeletal Pain Drug Pipeline Molecules by Stages
Figure 2 : Musculoskeletal Pain R&D Activities by Geography